Piramal Pharma Limited lists on BSE and NSE
MUMBAI, Oct. 19, 2022 /PRNewswire/ -- Piramal Pharma Limited (PPL) (Scrip Name: PPLPHARMA) today listed on the Indian stock exchanges, Bombay Stock Exchange (BSE) and National Stock Exchange
Stay updated with breaking news from Peter Deyoung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MUMBAI, Oct. 19, 2022 /PRNewswire/ -- Piramal Pharma Limited (PPL) (Scrip Name: PPLPHARMA) today listed on the Indian stock exchanges, Bombay Stock Exchange (BSE) and National Stock Exchange
MUMBAI, Oct. 19, 2022 /PRNewswire/ -- Piramal Pharma Limited (PPL) (Scrip Name: PPLPHARMA) today listed on the Indian stock exchanges, Bombay Stoc...
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
The Report articulates PPL's ESG strategic and operational framework, and execution roadmap, including specific objective targetsThe Report is prepared in accordance with GRI Standards and highlights
/PRNewswire/ -- Piramal Pharma Limited (PPL) today unveiled its Sustainability Report FY21–22 to provide a view of its performance on Environment, Social, and...